Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial.

McBride, Sean M; Wong, Douglas S; Dombrowski, John J; Harkins, Bonnie; Tapella, Patricia; Hanscom, Heather N; Collins, Sean P; Kaplan, Irving D

McBride, Sean M; Wong, Douglas S; Dombrowski, John J; Harkins, Bonnie; Tapella, Patricia; Hanscom, Heather N; Collins, Sean P; Kaplan, Irving D.

Affiliation

McBride SM; Harvard Radiation Oncology Program, Harvard University, 100 Blossom Street, 3, Boston, MA 02114, USA. smmcbride@partners.org

Cancer ; 118(15): 3681-90, 2012 Aug 01.

Article in En | MEDLINE | ID: mdl-22170628

Subject(s)

Adenocarcinoma/radiotherapy; Prostatic Neoplasms/radiotherapy; Radiosurgery/methods; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostate-Specific Antigen/blood; Radiosurgery/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Radiosurgery Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google